Lannett is a well respected leader in the manufacture of generic pharmaceuticals as well as being a one-stop, blend to bottle manufacturer. We market our products primarily to drug wholesalers, retail drug chains, repackagers, distributors and government agencies.

Through joint arrangements with other manufacturers and an active R&D program, we have successfully launched a number of new products such as "AB Rated" Levothyroxine Sodium tablets and Digoxin tablets.

Lannett was founded 1942 in Philadelphia, Pennsylvania. In April 2002, we began listing our stock (LCI) on the American Stock Exchange. To learn more about our Investment Opportunities, please visit our Investor Relations.